Pediatric oncology researcher Daniel Sinnett appointed director of the Network of Applied Genetic Medicine of the Fonds de recherche du Québec – Santé

Excerpts taken from:

MONTREAL, January 26, 2016 – Dr. Daniel Sinnett, PhD, researcher and head of the Viral and immune disorders and cancers axis at CHU Sainte-Justine, and professor in the Department of Pediatrics and the Department of Biochemistry and Molecular Medicine at Université de Montréal, was appointed director of the Newtwork of Applied Genetic Medicine (RMGA), which is one of the thematic networks of the Fonds de recherche du Québec – Santé (FRQS). His nomination reflects his roadmap as a leading figure in pediatric oncogenomics as well as CHU Sainte-Justine’s strong position in human and medical genetics. ʺMy intention is to position the network as a key stakeholder that has a pivotal role to play in debates and policy-making regarding genetics and medical genomics in Quebecʺ, Sinnett says.

Dr. Guy Rouleau, MD, PhD, former RMGA Director and current Director of the Montreal Neurological Institute and Hospital, showed enthusiastic about the nomination. “Dr. Sinnett is an outstanding researcher, with invaluable expertise in the field of genetics. Through his leadership and commitment to the organisation over the last 10 years and in his role as an executive committee member, Dr. Sinnett has contributed greatly to the RMGA mission of advancing genetic discoveries from the bench to the clinic. I couldn’t be more pleased to pass on role of Director to our esteemed colleague,” he said.

Daniel Sinnett is holder of the François-Karl Viau Research Chair in Pediatric Oncogenomics, and he is a member and co-founder of the Robert Cedergren Centre for Bioinformatics and Genomics. His research focuses on the fields of genomics and pediatric cancer, especially deciphering the genetic and molecular mechanisms underlying childhood leukemia